Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in OCGN — Ocugen, Inc.

CIK 19617 NEW YORK, NY
Back to OCGN Full portfolio

Position in OCGN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$240,380
+$220,695 QoQ
Shares Held
157,112
+1344.6% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 147 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority Sole 3% Shared 0% None 97%

Common Shares in OCGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,254,031 across 424 Biotechnology names. OCGN ranks #225 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in OCGN

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $240,380 157,112
2026-03-31 $19,685 10,876
2025-12-31 $642 476
2025-09-30 $775 476
2025-06-30 $31,958 32,948
2025-03-31 $100,009 141,658
2024-12-31 $238,773 296,615
2024-09-30 $118,068 119,021
2024-06-30 $169,333 109,248
2024-03-31 $642,756 391,925
2023-12-31 $105,116 182,813
2023-09-30 $53,790 134,477
2023-06-30 $1,650,749 3,040,056
2023-03-31 $2,679,746 3,141,557
2022-12-31 $4,895,412 3,766,868
2022-09-30 $5,575,290 3,132,186
2022-06-30 $7,477,985 3,294,268
2022-03-31 $13,251,946 4,015,742
2021-12-31 $15,114,898 3,321,956
2021-09-30 $4,014,508 559,124
2021-06-30 $948,767 118,153
2020-12-31 $38 21
2020-09-30 $20,243 65,300